Oncology Precision Medicine Market: Size, Trends, and Growth Insights The Oncology Precision Medicine industry is rapidly advancing, driven by technological innovations and increasing demand for targeted therapies. This evolving sector is reshaping cancer treatment paradigms, fostering significant industry growth backed by enhanced diagnostics and personalized treatment approaches. Market Size and Overview The Global Oncology Precision Medicine Market size is estimated to be valued at USD 186.3 million in 2026 and is expected to reach USD 432.8 million by 2033, exhibiting a compound annual growth rate (CAGR) of 12% from 2026 to 2033. The market report highlights increasing adoption of genomics-based cancer therapies and expanding investment in R&D as primary market drivers. Market insights reveal that rising incidences of cancer and advancements in biomarker research significantly impact the market scope. Industry trends underscore a shift toward integration of AI and machine learning in precision oncology, enhancing market revenue and overall market dynamics. Oncology Precision Medicine Market: https://www.coherentmi.com/industry-reports/oncology-precision-medicine-market